RxDoctor Payments DataLook up a doctor →

Subba Digumarthy, MD

Diagnostic Radiology · Boston, MANPI 1689623886

Payments from drug & device makers

$1,729,539in general payments, 2019–2025

Across 337 payments — averaging $5132.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$590K
  • Merck$509K
  • Boehringer Ingelheim Espana S.A.$191K
  • EMD Serono, Inc.$110K
  • Astrazeneca UK Limited$107K
  • Beigene, Ltd.$78K
  • plus $145K from 7 others
$27,100in research payments, 2019–2025

Across 8 payments — averaging $3387.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$27K

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,729,539 in reported general payments places this provider in the 95th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$162,823
Medicare patients
3,221
Services billed
7,625

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →